In previous editorials, Chapman and Otis in 2011 and Layfield in 2014 have summarized much of the work responsible for establishing the concept of critical diagnoses in surgical pathology and cytopathology. Both editorials end with a list of 8 key policy points needed for an effective strategy of handling and communicating critical diagnoses. We have developed and distributed a Web-based survey to elicit clinicians' attitudes regarding many of those key policy points, such as how, when, and to whom critical diagnoses should be reported; we have allowed some level of collaboration with the clinical staff when developing our communication policies as the Association of Directors of Anatomic and Surgical Pathology (ADASP) consensus statement recommends. We have identified important areas of disagreement between pathologists and clinicians regarding what entities should be considered critical and who should be responsible for correlating histologic findings with the larger clinical context. Identifying these discordant points of view and fostering interdepartmental agreement on the best practices in the communication of critical diagnoses is an important patient care and safety issue. Chapman and Otis have also suggested the importance of increased access to accurate patient information and the clinical history, including the level of clinical suspicion of malignancy, and of forming a periodic review and quality assurance process. Here we explore methods of increasing the ability of pathologists and cytopathologists to identify unexpected diagnoses, including optimization of their workstations for better access to the electronic medical record, and we examine the progress of quality assurance methods in surgical pathology and cytopathology since the ADASP consensus statement in 2012. Cancer Cytopathol 2018;126:970-979.
INTRODUCTION
Since the Association of Directors of Anatomic and Surgical Pathology (ADASP) published recommendations for critical diagnoses in anatomic pathology in 2006 and subsequently revised them in 2012, not much has changed. The current consensus statement provides 6 recommendations for the communication of urgent diagnoses, but it ultimately concludes that each institution should create its own policies. 1 Several studies have
polled pathologists about what should be considered an alert value in anatomic pathology. [2] [3] [4] The few studies that have analyzed nonpathologist perspectives include only a small number of clinician responses. [5] [6] [7] [8] Our survey represents the largest and most comprehensive survey-based investigation of the specific preferences of clinicians with respect to how, when, and to whom alert-urgent diagnoses should be communicated. One factor that has changed since the original ADASP recommendations, which used the phrases critical value and critical diagnosis, is the terminology. Critical value is an established phrase in clinical pathology used to denote a result that is time-sensitive and suggests an imminent, life-threatening condition. 9 Several other terms have been applied to results in anatomic pathology in an attempt to communicate that the result is not time-sensitive but is rather information-sensitive. Renshaw et al 8 showed that changing the terminology away from critical value/result can help in achieving agreement between pathologists and nonpathologists about what should be considered an alert value. Alternative terminology or otherwise closely related terms
Cancer Cytopathology December 2018 in the literature include the following: critical diagnosis; urgent diagnosis; treatable immediately, life-threatening diagnosis; significant and unexpected diagnosis; and, at our institution, alert-urgent diagnosis. [1] [2] [3] [4] 8, 10 Unfortunately, this diversity of terminology has not prevented persistent discordant opinions between clinicians and pathologists about what qualifies as an alert value, and resolving the differences in these points of view remains an important issue affecting patient safety. We aim to better understand treating clinicians' attitudes, preferences, and concepts regarding critical values in surgical pathology and cytopathology. This information can help us to identify areas that we can modify to improve the delivery system of these important diagnoses.
MATERIALS AND METHODS
This study was a Web-based survey with participants from the Baystate Medical Center physician network. Survey development was guided by our laboratories' current policies, as outlined in our alert-urgent diagnosis quality manual, and by the 2012 ADASP consensus statement on critical and unexpected values. 1 The survey consisted of 10 multiple-choice questions built with SurveyMonkey, with either single-answer or multipleanswer options, and an option to leave free-text comments (Fig. 1) Results were exported as a spreadsheet and analyzed in Microsoft Excel. The responses were stratified by position (attending, resident/fellow, or other) and specialty (medicine, surgery, pathology, or other). A simple data analysis was performed, and the frequency of responses was observed to identify possible discrepancies in the attitudes of alert-urgent diagnoses between pathologists and nonpathologists.
RESULTS
Of the 1308 attending physicians and 330 residents and fellows to whom the survey was sent, 124 submitted responses, and this yielded an overall response rate of 7.6%. According to the submitted responses, 72% were attending physicians, 23% were residents/fellows, and 4% were other. Seventy-two percent were grouped into the specialty of medicine, 11% were grouped into the specialty of surgery, 7% were grouped into the specialty of pathology, and 9% were classified as other (Table 1) .
Survey respondents were given a list of 22 potential diagnoses and were asked to state which entities they would consider alert-urgent. Among the least commonly chosen answers were "fat in a GI biopsy" (8%), "fat in an endometrial biopsy" (15%), and "entirely at the discretion of the individual attending pathologist" (16%). The entities that were considered alert-urgent by a majority of respondents included the following: "new, unexpected malignant diagnosis (63%), "new malignant diagnosis, even if expected," (54%), "major discrepancy between Cancer Cytopathology December 2018 Cancer Cytopathology December 2018 intraoperative diagnosis and final diagnosis" (56%), "major discrepancy between onsite cytology interpretation and final diagnosis" (53%), "major discrepancy in consultation material between original and consultant diagnosis" (56%), "major specimen handling/processing issues" (56%), and "amended report with significant clinical impact" (61%). When the respondents were stratified by specialty, a few data trends emerged. For almost every entity, more pathology respondents considered it alert-urgent than medicine or surgery respondents. The 2 exceptions were "new malignant diagnosis, even if expected" and "all malignant diagnoses, even if prior diagnosis exists." A new but expected malignant diagnosis was considered alert-urgent by only 33% of pathologists and 36% of surgeons, but a majority from the medicine group (57%) did consider it alert-urgent. Although 0% of pathologists believed that "all malignant diagnoses" should be considered alert-urgent, a minority from the medicine (23%) and surgery groups (21%) did indicate this point of view (Fig. 2) .
Regarding how the pathologist should determine whether a malignant diagnosis would be expected or unexpected, most physicians suggested considering "a diagnosis that is inconsistent with the clinical information provided to the pathologist on the specimen requisition sheet" (79%) and "a malignant diagnosis with no prior history of malignancy" (69%) as unexpected.
In the event that no clinical information is provided to the pathologist on the requisition sheet, a majority of respondents believed that the pathologist should assume "any malignant result is unexpected and alert-urgent" (54%). Fewer respondents (40%) felt that the pathologist should "refer to the hospital medical record to judge the significance of the result." However, when the respondents were stratified by specialty, we observed that the majority of pathologists (78%) felt that electronic medical record investigation was appropriate, whereas a minority of nonpathologists (37%) did (Fig. 3) .
Nearly all respondents agreed that attending physicians were appropriate contacts for the communication of Cancer Cytopathology December 2018 alert-urgent diagnoses (92%). The majority of respondent agreed that residents/fellows were appropriate contacts (75%), but only a minority believed that nurses (44%) or administrative staff (16%) were appropriate contacts.
In response to acceptable methods of communication, the most popular answers were by telephone (73%), by pager (71%), and by a secure communications platform such as Imprivata Cortext (66%). Notification via text message (26%), e-mail (20%), voicemail (13%), or fax machine (8%) was least likely to be chosen as an acceptable method.
If the pathologist is unable to contact the ordering physician, 92% of the respondents suggested contacting the covering physician with the alert-urgent diagnosis. Only a minority of respondents suggested that the pathologist might also try "calling the chief of the applicable service" (38%) or "calling the ordering physician using home and cell phone numbers" (32%); however, when the respondents were stratified by specialty, we found that a majority of pathologists (78%) believed that these were also acceptable options.
Sixty percent of the respondents expected an alert-urgent diagnosis to be communicated within 24 hours of the final diagnosis being rendered. Twenty-six percent indicated that the pathologist should initiate communication within 1 hour of making the final diagnosis.
Finally, 19% of the responding physicians document having received an alert-urgent diagnosis in part of the patient's daily progress note, whereas 48% create an independent document, such as a phone message note. Six percent of all respondents admitted to not documenting the encounter at all.
DISCUSSION

Alert-Urgent Diagnoses in Cytopathology
Layfield's commentary on critical diagnoses in cytopathology from 2014 concludes with 8 key policy points needed for an effective strategy of handling critical diagnoses in cytology 11 ; they are in some ways similar to the 8 policy points described at the end of the commentary by Chapman and Otis in 2011, 10 and this indicates that the same issues that we confront today have been lingering for many years. The elements they describe that contribute to operational success include defining a time period in which diagnoses should be reported, designating individuals to receive the report, creating a critical diagnosis entity list, creating proper documentation of issuing and receiving reports, and establishing an effective means of communication. The data from our survey examining clinicians' perspectives of these issues have helped our institution to create alert-urgent policies in collaboration with clinical staff, as is recommended in the ADASP consensus statement. 1 Chapman and Otis have further suggested the importance of increased access to accurate Cancer Cytopathology December 2018 patient information and the clinical history, including the level of clinical suspicion of malignancy, and of forming a periodic review and quality assurance process. These ideas will briefly be discussed here. Even more so in cytology than surgical pathology, the criticalness of the diagnosis depends on the larger clinical picture. For example, the finding of herpes in an otherwise unremarkable Papanicolaou test may be mentioned as a second-line diagnosis; however, if the patient is pregnant, that same finding becomes alert-urgent and warrants special communication to the ordering physician. Similarly, urine containing polyomavirus in an otherwise healthy patient has much different implications then that same finding in an immunocompromised or renal transplant patient. Data from our survey highlight the current discrepant perceptions between pathologists and clinicians regarding alert-urgent diagnoses specific to cytopathology. One hundred percent of the polled pathologists considered the finding of herpes in a Papanicolaou test of a pregnant patient to be alert-urgent, whereas 25% of nonpathologists did. Because the clinicians are those who provide the relevant clinical history on our requisition forms, aligning our expectations of what clinical history would elevate an otherwise standard diagnosis to an alert-urgent status remains an important patient safety issue. As the role of cytopathologists evolves beyond screening patients for precancerous lesions to confirming the presence or absence of metastatic disease and performing a rapid onsite evaluation of computed tomography and ultrasound-guided biopsies, having never met the patient is no excuse for not knowing the patient. The relationship between the cytopathologist and the patient has aptly been compared with ships passing in the night; this illustrates the importance to the cytopathologist of having effective access to the electronic medical record because he or she has no opportunity to glean relevant information from the patient or even the clinical team. 12 
Increasing Pathologist and Cytopathologist Access to Patient Information via Workstation Modernization
The critical nature of a new, unexpected malignant diagnosis appears to be self-evident, and a majority of the respondents to our survey agreed (61%). Less clear is the critical nature of a new malignant diagnosis when the result is expected. It also remains unclear how a pathologist should determine the expectedness of a result. A lack of clinical information provided to the pathologist on the specimen requisition form may further contribute to the uncertainty of any given result being expected or unexpected. In the age of the electronic medical record, the pathologist often has access to these relevant clinical data; however, combing through the extensive documentation of medically complex patients to piece together the thought process of the treating physician is labor-intensive, especially when the case load of modern-day pathologists is taken into account. Still, 78% of the responding pathologists indicated that such medical record investigation to determine whether their diagnosis would be unexpected was their responsibility.
As the medical record has modernized into the electronic age, the pathologist work station has lagged behind. A microscope and a computer attached to 1 standard-size monitor are often our only tools for investigating the past clinical history and past surgical pathology history, correlating the relevant data with the microscopic images in front of us, referencing the relevant literature, and synthesizing a final report. This often involves 3 or 4 separate applications without the screen space to visualize all of them at once. Having to input by hand the medical record numbers and patient names into multiple applications increases the opportunity for pairing the wrong history to a specimen. Modifications to the existing work station setup, such as multiple, large-area monitors and a bar code scanner linked to the clinical and pathology electronic medical records, are quickly becoming essential. Modernization of the pathologist work station would enable us to better access the clinical information necessary to determine whether special communication with the treating team is warranted, and it would improve the delivery of alert-urgent diagnoses. Interestingly, our data suggest a disagreement between pathologists and nonpathologists about who is responsible for correlating the histologic diagnosis with the clinical picture: only 38% of the clinicians thought that such medical record investigation by the pathologist was necessary, with 57% suggesting that the pathologist should forgo such investigation and assume that any malignant result in the absence of a provided clinical history is unexpected and alert-urgent.
One of the free-text comments that we received at the end of our survey concerning the delivery of alerturgent diagnoses read as follows:
The current radiology system has different color codes. A page is sent to the physician, a message in CIS and a call is sent to the answering service. You could answer either way and it would be logged in CIS as read. You may also document the action taken.
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This comment illustrates the importance of a modern, integrated picture archiving and communication system (PACS) and the additional automated communication tools that it provides. As digital whole-slide imaging becomes the norm in laboratories in the future, an integrated pathology PACS system will hopefully follow. It would be prudent to begin upgrading the hardware that such a system would require. The modernization of radiology leading to its PACS system began in the 1990s and early 2000s when radiologists transitioned to digital image displays. Sharma et al 13 found that radiologists often have 3 to 5 applications open, including a case list, an electronic medical record, a Web browser, e-mail, and a paging directory, in addition to their primary imaging application. To facilitate their needs, the radiology workspace has evolved to include dedicated diagnostic monitors and nondiagnostic monitors; this allows more screen space for visualizing more applications simultaneously and correlating their image-based findings with the patient's overall clinical situation. Large-area monitors have been shown to decrease time spent managing windows by 90%; however, toggling data streams and performing window management on a single, small-area screen may be more than simply a cumbersome workflow. 14 As Beale et al 15 suggested, multitasking is itself a task, and having more information available in the foreground reduces multitasking demands and allows the diagnostician to give more attention to the case. Although a consensus for an optimal workstation design has not been reached, most radiologists use 2 to 4 diagnostic monitors, and it has been noted that adding more introduces too much "visual noise" and inconvenience. 16 We were unable to find any studies of how pathologists use the screen space of their monitors or how many applications they typically have open to complete a case.
Quality Assurance of Critical Diagnosis Policies in Anatomic Pathology and Cytopathology
In its consensus statement, the ADASP noted a lack of critical diagnosis policy audits and stated that its literature search revealed "no reports of systematic documentation of failed communications in anatomic pathology with evaluation of the consequences of those failures." 1 Our survey shows some heterogeneity in clinician documentation practices of alert-urgent diagnoses, with 6% admitting to not documenting having received an alert-urgent diagnosis at all. Interestingly, other institutions have found similar rates of 6% to 8% of a failure to document the communication of critical diagnoses. 17, 18 Introducing a specific protocol for where to document these important conversations, such as an alert-urgent communication note type, would make tracking such cases easier in the electronic medical record. It is also difficult to track the communication of diagnoses that were unexpected because they do not represent a list of specific diagnoses but represent specific situations. The University of Michigan hospitals developed a rules-based natural language parser using the laboratory information system for the initial identification of cases that met the criteria for critical diagnoses but lacked an indication of appropriate clinical discussion with the ordering physician. 17 Specifically, the system automatically scanned anatomic pathology reports for 20 to 30 key phrases indicating a cancer diagnosis and for 10 to 15 key phrases of text suggesting that communication with the clinician had occurred. Each day, the directors of anatomic or surgical pathology received a list of reports that the system had flagged as having a cancer diagnosis but none of the key terms suggesting that the pathologist had talked to the clinician. Next, they investigated each case by checking the patient's electronic medical record for evidence that the clinician knew about the cancer diagnosis. In the absence of such evidence, the pathologist would contact the clinician. Data were collected from 2006 to 2010, during which time a total of 13,790 cases were flagged by the automated system, with a mean number of 13 events per day. , which sent all final reports to the submitting physician via e-mail and fax and notified him or her with a pager alert. They stressed that the automated process did not supersede the need for verbal communication but provided additional communicative tools and, importantly, marked cases of critical diagnoses with a code that could be easily reviewed. Whenever a pathology report was signed out with a TC66 code, the quality assurance division also received a notification. Quality assurance personnel could then examine each TC66-coded report to ensure that the critical diagnosis was communicated appropriately and that such communication was documented in the cytology report. Their retrospective review included 4 academic hospitals and 9 community hospitals, and it generated 1687 cytopathology reports marked with the TC66 code between 2011 and 2016. They found that between 2015 and 2016, 35% of TC66 reports from academic hospitals and 90% of such reports from community hospitals failed to actually meet the critical diagnosis criteria set by the institutional policy. The majority of these critical cases were found to be first-time positive or suspicious-for-malignancy specimens for which there was already a clinical suspicion of malignancy. Although the communication of a noncritical diagnosis with alert-urgent protocols may be less deleterious than communicating a critical diagnosis with a routine protocol, the practice is still a concern for patient safety, especially if the mischaracterization rate is so high. Reporting with alert-urgent protocols is time-consuming, disrupts the daily workflow, and may lead to the dismissal of subsequent reports marked as critical. Because the criticalness of a malignant diagnosis depends on the clinical expectation, better communication between clinicians and cytopathologists or better investigative tools for cytopathologists in community settings have the potential to greatly affect this aspect of patient safety.
Limitations
The response rate was a significant limitation of our study. Because only 7.6% of the 1638 people surveyed responded, the data should not be generalized. Although trends between the answers of pathologists and nonpathologists were observed, when they were separated by specialty, the quantity of responses was not sufficient for us to analyze statistically significant differences.
All participants of the survey were from the Baystate Health System, which includes a teaching hospital, a children's hospital, 3 community hospitals, and approximately 80 other medical practices, all located in the region of western Massachusetts.
CONCLUSIONS
Although the concept of critical diagnoses in surgical pathology and cytopathology is well recognized among pathologists, it does little good unless the concept is also recognized by our clinical colleagues. Our survey demonstrated areas of agreement and disagreement among physicians regarding key critical diagnosis policy issues, although a larger scale, multi-institution survey would be required to examine whether the trends that we observed in our data represent significant differences.
One of the free-text comments that we received at the end of our survey highlights the importance of concordant expectations of communication between cytopathologists and clinicians:
Just a few weeks ago I had a patient have positive cytology on a pleural fluid sample which was missed [by] myself and two consultant teams for 2 days leading to a delay in diagnosis which was unexpected. This caused stress to the patient and family and hurt the relationship between the primary team and patient. I would love to have a system in place so I know that if something like this is found that I do not find out about it by stumbling upon it in the medical record.
To minimize the occurrence of the illustrated scenario, the cytopathologist must be able to determine what the clinical team is expecting to decide whether initiating special communication is necessary. Fostering agreement within the interdepartmental medical team about what findings should be considered alert-urgent or unexpected and how they should be communicated is essential to improving patient care and safety. However, in the inevitable event of a breakdown in communication, such as when Cancer Cytopathology December 2018 the pathologist receives a specimen requisition sheet with little or no clinical history provided, the burden is placed on the pathologist to investigate the medical record and consider the histologic findings within the greater clinical context. Giving pathologists additional investigative and communicative tools and maintaining a robust quality assurance system are critical to overcoming this obstacle.
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